Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.

Neuroradiology - 1 Jun 2017

Lin Yu, Xing Zhen, She Dejun, Yang Xiefeng, Zheng Yingyan, Xiao Zebin, Wang Xingfu, Cao Dairong

Abstract excerpt

PURPOSE: Currently, isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion are proven diagnostic biomarkers for both grade II and III oligodendrogliomas (ODs). Non-invasive diffusion-weighted imaging (DWI), susceptibility-weighted imaging (SWI), and dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI) are widely used to provide physiological information (cellularity, hemorrhage,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Contrast Media

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diffusion Magnetic Resonance Imaging

Share to Isocitrate Dehydrogenase

Share to Magnetic Resonance Imaging

Share to Neoplasm Grading

Share to Oligodendroglioma

Share to Organometallic Compounds

Source

Open in PubMed Open full text

Identifiers

PMID: 28474187
DOI: 10.1007/s00234-017-1839-6
PMCID: PMC5446560

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.PMID 28474187Read ↗

The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.Semantic proximity Read ↗

Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours.Semantic proximity Read ↗

Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?Semantic proximity Read ↗

Perfusion, diffusion, and anatomical MRI characteristics of pathologically confirmed malignant transformation in IDH-mutant gliomas.Semantic proximity Read ↗

IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing regionSemantic proximity Read ↗

Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.Semantic proximity Read ↗

RCBVmax from DSC Perfusion MRI as a Supportive Imaging Biomarker for Differentiating IDH-Mutant Astrocytomas and Oligodendroglioma.Semantic proximity Read ↗

Differentiation between oligodendroglioma genotypes using dynamic susceptibility contrast perfusion-weighted imaging and proton MR spectroscopy.Semantic proximity Read ↗

MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendroglioma.Semantic proximity Read ↗

Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI.Semantic proximity Read ↗

Oligodendroglioma: pathology, molecular mechanisms and markersSemantic proximity Read ↗

Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.